Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies

Unmanipulated haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) has been an established treatment to cure high-risk leukemia/lymphoma. Relapse is the main cause of treatment failure for patients with relapsed/refractory disease or with very high-risk gene mutations such as TP53...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Hematol
Autors principals: Gao, Xiao-Ning, Lin, Ji, Wang, Shu-Hong, Huang, Wen-Rong, Li, Fei, Li, Hong-Hua, Chen, Jing, Wang, Li-Jun, Gao, Chun-Ji, Yu, Li, Liu, Dai-Hong
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6334751/
https://ncbi.nlm.nih.gov/pubmed/30143831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-018-3482-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars